Active Biomarkers has decades of experience in assay development, validation, and the implementation of immunological methods for sample testing. Our experts take great care in understanding the science of your drug and target indication, not forgetting practical constraints of clinical development, to provide you with analytical solution(s) to meet your expectations.
With a strong track record in 4 major therapeutic areas (immuno-oncology, infectious diseases, inflammatory conditions, and neurological disorders), we routinely analyze a broad range of biological matrices (blood-derived samples, including PBMCs, feces, CSF, skin, bone marrow, etc.), as well as various species, including human samples, non-human primates, and murine models.
Active Biomarkers relies on one of the most comprehensive technological parks in Europe to propose expert solutions for the analysis of:
Active Biomarkers is equipped with the Gyrolab xPlore platform and offers the development and testing of Gyrolab immunoassays for the following applications:
Gyrolab platform brings key advantages for method development thanks to the high throughput, the flexibility to screen multiple assay configurations in a single run, and the low sample volume. In our opinion, these features allow us to reconcile method development to short timelines and cost-efficacy.
Gyrolab is a platform of choice for method development (PK, ADA, Soluble Biomarkers) when